The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer
Abstract
Cell-membrane-coated nanoparticles are widely studied due to their inherent cellular properties, such as immune escape and homologous homing. A cell membrane coating can also maintain the relative stability of nanoparticles during circulation in a complex blood environment through cell membrane encapsulation technology. In this study, we fused a murine-derived ID8 ovarian cancer cell membrane with a red blood cell (RBC) membrane to create a hybrid biomimetic coating (IRM), and hybrid IRM camouflaged indocyanine green (ICG)-loaded magnetic nanoparticles (Fe 3 O 4 -ICG@IRM) were fabricated for combination therapy of ovarian cancer. Fe 3 O 4 -ICG@IRM retained both ID8 and RBC cell membrane proteins and exhibited highly specific self-recognition of ID8 cells in vitro and in vivo as well as a prolonged circulation lifetime in blood. Interestingly, in the bilateral flank tumor model, the IRM-coated nanoparticles also activated specific immunity, which killed homologous ID8 tumor cells but had no effect on B16-F10 tumor cells. Furthermore, Fe 3 O 4 -ICG@IRM showed synergistic photothermal therapy, resulting in the release of whole-cell tumor antigens by photothermal-induced tumor necrosis, which further enhanced antitumor immunotherapy for primary tumor and metastatic tumor by activating CD8 + cytotoxic T cells and reducing regulatory Foxp3 + T cells. Together, the biomimetic Fe 3 O 4 -ICG@IRM nanoparticles showed synergistic photothermal-immunotherapy for ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P.-A., Zheleznyak, A., Fang, Y.-F., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 1,970
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Chen, Z., Zhao, P., Luo, Z., Zheng, M., Tian, H., Gong, P., Gao, G., Pan, H., Liu, L., Ma, A., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b04695 · Cited by 895
Finn, O. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072739 · Cited by 774
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
T cell-engaging therapies — BiTEs and beyond
Goebeler, M.-E., & Bargou, R. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0347-5 · Cited by 644
Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors
Sun, H., Su, J., Meng, Q., Yin, Q., Chen, L., Gu, W., Zhang, P., Zhang, Z., Yu, H., Wang, S., et al. (2016) · Advanced Materials · doi:10.1002/adma.201602173 · Cited by 640
Self-citationGao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 551
Self-citationCancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging
Rao, L., Bu, L., Cai, B., Xu, J., Li, A., Zhang, W., Sun, Z., Guo, S., Liu, W., Wang, T., et al. (2016) · Advanced Materials · doi:10.1002/adma.201506086 · Cited by 530
Self-citationWang, D., Dong, H., Li, M., Cao, Y., Yang, F., Zhang, K., Dai, W., Wang, C., & Zhang, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b08355 · Cited by 515
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 513
Self-citationZhu, J.-Y., Zheng, D.-W., Zhang, M.-K., Yu, W.-Y., Qiu, W.-X., Hu, J.-J., Feng, J., & Zhang, X.-Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02786 · Cited by 498
Chu, M., Shao, Y., Peng, J., Dai, X., Li, H., Wu, Q., & Shi, D. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.086 · Cited by 451
Piao, J.-G., Wang, L., Gao, F., You, Y.-Z., Xiong, Y., & Yang, L. (2014) · ACS Nano · doi:10.1021/nn503779d · Cited by 426
Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
Raj, S., Khurana, S., Choudhari, R., Kesari, K. K., Kamal, M. A., Garg, N., Ruokolainen, J., Das, B. C., & Kumar, D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.002 · Cited by 425
Recent advances in CAR-T cell engineering
Huang, R., Li, X., He, Y., Zhu, W., Gao, L., Liu, Y., Gao, L., Wen, Q., Zhong, J. F., Zhang, C., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00910-5 · Cited by 402
Self-citationJiang, Q., Liu, Y., Guo, R., Yao, X., Sung, S., Pang, Z., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.021 · Cited by 398
Self-citationPhotothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation
Liang, X., Ye, X., Wang, C., Xing, C., Miao, Q., Xie, Z., Chen, X., Zhang, X., Zhang, H., & Mei, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.027 · Cited by 386
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Han, X., Shen, S., Fan, Q., Chen, G., Archibong, E., Dotti, G., Liu, Z., Gu, Z., & Wang, C. (2019) · Science Advances · doi:10.1126/sciadv.aaw6870 · Cited by 349
Goon, I. Y., Lai, L. M. H., Lim, M., Munroe, P., Gooding, J. J., & Amal, R. (2009) · Chemistry of Materials · doi:10.1021/cm8025329 · Cited by 288
Liu, W.-L., Zou, M.-Z., Liu, T., Zeng, J.-Y., Li, X., Yu, W.-Y., Li, C.-X., Ye, J.-J., Song, W., Feng, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11157-1 · Cited by 272
Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments
Pan, J., Hu, P., Guo, Y., Hao, J., Ni, D., Xu, Y., Bao, Q., Yao, H., Wei, C., Wu, Q., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08550 · Cited by 270
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Yu, X., Dai, Y., Zhao, Y., Qi, S., Liu, L., Lu, L., Luo, Q., & Zhang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-14906-9 · Cited by 243
Chen, Q., Huang, G., Wu, W., Wang, J., Hu, J., Mao, J., Chu, P. K., Bai, H., & Tang, G. (2020) · Advanced Materials · doi:10.1002/adma.201908185 · Cited by 236
Liu, W., Zou, M., Liu, T., Zeng, J., Li, X., Yu, W., Li, C., Ye, J., Song, W., Feng, J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201900499 · Cited by 190
Ryan, G. M., Kaminskas, L. M., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.051 · Cited by 138
Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy
Zhu, D., Xie, W., Xiao, Y.-S., Suo, M., Zan, M., Liao, Q., Hu, X., Chen, L., Chen, B., Wu, W., et al. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa9ca1 · Cited by 128
Ou, W., Jiang, L., Thapa, R. K., Soe, Z. C., Poudel, K., Chang, J., Ku, S., Choi, H., Yong, C. S., & Kim, J. O. (2018) · Theranostics · doi:10.7150/thno.26758 · Cited by 117
Lee, M. J.-E., Omid Veiseh, A., Bhattarai, N., Sun, C., Hansen, S. J., Ditzler, S. H., Knoblaugh, S. E., Lee, D., Ellenbogen, R. G., Zhang, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009536 · Cited by 111
Role of CD47 in Erythroid Cells and in Autoimmunity
Oldenborg, P. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819042000201989 · Cited by 103
Zhou, F., Yang, J., Zhang, Y., Liu, M., Lang, M. L., Li, M., & Chen, W. R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1126 · Cited by 98
Sun, C., Li, X., Guo, E., Li, N., Zhou, B., Lü, H., Huang, J. M., Xia, M., Shan, W., Wang, B., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1090-1 · Cited by 82
Self-citationYuan, G., Yuan, Y., Xu, K., & Luo, Q. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018776 · Cited by 55
Nguyen, T. D. T., Marasini, R., Rayamajhi, S., Aparicio, C., Biller, D. S., & Aryal, S. (2020) · Nanoscale · doi:10.1039/d0nr00039f · Cited by 43
Muñoz, N. M., Dupuis, C. J., Williams, M. L., Dixon, K. A., McWatters, A., Avritscher, R., Bouchard, R. R., Kaseb, A. O., Schachtschneider, K. M., Rao, A. U. K., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01522-y · Cited by 21
Xu, Y., Li, W., Chen, S., Huang, B., Pei, W., & Niu, C. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.599107 · Cited by 16
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
Liu, H., Su, Y.-Y., Jiang, X.-C., & Gao, J.-Q. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01252-0 · Cited by 302
Zhang, M., Liu, C., Tu, J., Tang, M., Ashrafizadeh, M., Nabavi, N., Sethi, G., Zhao, P., & Liu, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02305-x · Cited by 259
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Cui, Y., Lv, B., Li, Z., Ma, C., Gui, Z., Geng, Y., Liu, G., Sang, L., Xu, C., Min, Q., et al. (2024) · Small · doi:10.1002/smll.202303494 · Cited by 81
Self-citation
Metadata
- Authors
- Xiong, J., Wu, M., Chen, J., Liu, Y., Chen, Y., Fan, G., Liu, Y., Cheng, J., Wang, Z., Wang, S., Liu, Y., & Zhang, W.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-12-03
- Volume
- 15
- Issue
- 12
- Pages
- 19756-19770
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3217799976
- Cited by
- 266
- References
- 41
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.